These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 4580383)

  • 21. [Studies on the microbial resistance to the drug combination sulfamethoxazole trimethroprim with special reference to enterococci].
    Gärtner H; Dieterich F
    Arzneimittelforschung; 1973 Apr; 23(4):597-600. PubMed ID: 4197072
    [No Abstract]   [Full Text] [Related]  

  • 22. [In vitro bactericidal activity of trimethoprim combined with different antibiotics].
    Cluzel R; Sirot J; Cluzel M; Joly B
    Pathol Biol (Paris); 1972 Nov; 20(21):871-9. PubMed ID: 4566242
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antibacterial action in vitro of the association of trimethoprim and sulfamethoxazole on Salmonella typhi and paratyphi].
    Galanti G; De Petrillo V; Carassiti P
    G Mal Infett Parassit; 1971 Jan; 23(1):38-40. PubMed ID: 5093379
    [No Abstract]   [Full Text] [Related]  

  • 24. [In vitro testing of Ro 6-2580-9 or Ro 6-2580-11 with the disc test].
    Holl KM
    Chemotherapy; 1969; 14():Suppl:30-7. PubMed ID: 5379871
    [No Abstract]   [Full Text] [Related]  

  • 25. The in vitro demonstration of the efficacy of trimethoprim as an antibacterial agent in a comparative bacteriological study of the effects of trimethoprim, sulfamethoxazole and the combination trimethoprim-sulfamethoxazole.
    Küchler R; Koch UJ
    Chemotherapy; 1973; 18(4):242-52. PubMed ID: 4571975
    [No Abstract]   [Full Text] [Related]  

  • 26. Trimethoprim-resistant coliforms.
    Lacey RW; Bruten DM; Gillespie WA; Lewis EL
    Lancet; 1972 Feb; 1(7747):409-10. PubMed ID: 4110643
    [No Abstract]   [Full Text] [Related]  

  • 27. Regression line analysis of the synergistic effect for the combination of trimethoprim-sulphamethoxazole.
    Dornbusch K
    Chemotherapy; 1971; 16(4):229-38. PubMed ID: 5121717
    [No Abstract]   [Full Text] [Related]  

  • 28. The sensitivity of Pseudomonas pseudomallei to trimethoprim and sulphamethoxazole in vitro.
    Bassett DC
    J Clin Pathol; 1971 Dec; 24(9):798-800. PubMed ID: 5139985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The susceptibility of Serratia marcescens to sulfamethoxazole, trimethoprim, and trimethoprim-sulfamethoxazole.
    Adeniyi-Jones C; Neilly S; Roberts RS; Kaufmann NR
    J Infect Dis; 1973 Nov; 128():Suppl:534-42 p. PubMed ID: 4585956
    [No Abstract]   [Full Text] [Related]  

  • 30. Trimethoprim: biochemical basis for sulphonamide potentiation.
    Hitchings GH
    S Afr Med J; 1970 Aug; 44(32):Suppl:1-2. PubMed ID: 5505880
    [No Abstract]   [Full Text] [Related]  

  • 31. [Methods for testing bacterial resistance to active substance combinations using trimethoprim and sulfamethoxazol as an example].
    Gallien R; Schönfeld H
    Arzneimittelforschung; 1971 May; 21(5):577-83. PubMed ID: 4936787
    [No Abstract]   [Full Text] [Related]  

  • 32. [Studies of combination trimethoprim-sulfamethoxazole in urology].
    Schulman CC
    Schweiz Rundsch Med Prax; 1971 Jan; 60(1):15-7. PubMed ID: 5279595
    [No Abstract]   [Full Text] [Related]  

  • 33. [Liver functional state and antibacterial activity of trimethoprim-sulfamethazole in blood, bile and urine in humans].
    Neuman M; Kazmierczak A; Charbonnier A
    Therapie; 1972; 27(6):1069-80. PubMed ID: 4661222
    [No Abstract]   [Full Text] [Related]  

  • 34. [Activity of the trimethoprim-sulfamethoxazole association in experimental toxoplasmosis in mice. Histochemical study].
    Cellesi C; Barberi A; Terragna A
    Boll Ist Sieroter Milan; 1973; 52(1):70-6. PubMed ID: 4714452
    [No Abstract]   [Full Text] [Related]  

  • 35. Determination of bacterial resistance to trimethoprim-sulphamethoxazole using the single disc diffusion method.
    Kayser FH; Wüst J
    Chemotherapy; 1973; 18(3):162-8. PubMed ID: 4567769
    [No Abstract]   [Full Text] [Related]  

  • 36. [Resistance determinations in microorganisms causing dysenteria with regard to sulfamethoxazol-trimethoprim].
    Titze W
    Arzneimittelforschung; 1971 May; 21(5):597-8. PubMed ID: 5109683
    [No Abstract]   [Full Text] [Related]  

  • 37. [Activity of the trimethoprim-sulfamethoxazole association in experimental toxoplasmosis in mice. Histological and immuno-histological study].
    Terragna A; Cellesi C; Barberi A
    Boll Ist Sieroter Milan; 1973; 52(1):60-9. PubMed ID: 4576904
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of co-trimoxazole on faecal enterobacteria: no emergence of resistant strains.
    Moorhouse EC; Farrell W
    J Med Microbiol; 1973 May; 6(2):249-52. PubMed ID: 4575275
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of nocardial infection with trimethoprim-sulphamethoxazole.
    Pavillard ER
    Med J Aust; 1973 Jun; 1(2):Suppl:65-9. PubMed ID: 4580590
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of the drug combination trimethoprim-sulfamethoxazole on the intestinal flora of man in short- and long-term administration].
    Knothe H
    Arzneimittelforschung; 1973 May; 23(5):704-8. PubMed ID: 4197002
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.